ImmunityBio (IBRX) Net Equity Issued and Repurchased (2014 - 2026)
ImmunityBio (IBRX) recorded Net Equity Issued and Repurchased of $53.54 million in Q1 2026, compared with $220,000 a year earlier.
Powered by 
Analysis
ImmunityBio (IBRX) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
For FY2024, ImmunityBio reported Net Equity Issued and Repurchased of $73.28 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 15.8% (FY2019 to FY2024).
- Across earlier years, Net Equity Issued and Repurchased came in at $5.46 million in FY2021 (-93.7%) and $86.3 million in FY2020 (+145.5%).
- The Q1 2026 figure is the highest quarterly Net Equity Issued and Repurchased since Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | ImmunityBio | 7.17 Bn | 5.86 Bn | 47.55 Mn | 2.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.65 Mn |
| Jun 30, 2026 | 886,000.00 |
| Mar 31, 2026 | 16.38 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 889,000.00 |
| Mar 31, 2025 | 3.00 Mn |
| Sep 30, 2024 | 15.62 Mn |
| Jun 30, 2024 | 43.55 Mn |
| Mar 31, 2024 | 14.12 Mn |
| Dec 31, 2023 | -74.19 Mn |
| Sep 30, 2023 | 37.46 Mn |
| Jun 30, 2023 | -126,000.00 |
| Mar 31, 2023 | 126,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | -136.60 Mn |
| Sep 30, 2021 | 42.60 Mn |
| Jun 30, 2021 | 98.34 Mn |
| Mar 31, 2021 | 1.12 Mn |
API Access
ImmunityBio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();